What drugs does HETERO LABS make?

HETERO LABS has 5 FDA-approved drugs including AMLODIPINE BESYLATE AND VALSARTAN.

What therapeutic areas does HETERO LABS focus on?

HETERO LABS focuses primarily on Dermatology and Infectious Disease and 1 other therapeutic areas.

← Back

Data updated: Mar 10, 2026

HETERO LABS

DermatologyInfectious DiseaseCardiovascular

Generics

HETERO LABS is a generic drug manufacturer focused on Dermatology, Infectious Disease, Cardiovascular.

2016

Since

Drugs

Trials

Approved (2yr)

Key Drugs

AMLODIPINE BESYLATE AND VALSARTAN

amlodipine besylate

Cardiovascular

Calcium channel 3 indications · 2013

Recent Activity

LINEZOLID 2025-12-08

AMLODIPINE BESYLATE AND VALSARTAN 2025-10-15

Labeling

AMLODIPINE BESYLATE AND VALSARTAN 2025-10-15

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Dermatology 50%

2 drugs

Infectious Disease 25%

1 drugs

Cardiovascular 25%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

Baxter specialty

Infectious Disease, Cardiovascular, Dermatology

B BRAUN specialty

Infectious Disease, Dermatology, Cardiovascular

COSETTE other

Cardiovascular, Dermatology, Infectious Disease

BAUSCH AND LOMB specialty

Cardiovascular, Infectious Disease, Dermatology

FOUGERA PHARMS other

Dermatology, Infectious Disease, Cardiovascular

HETERO LABS

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (5)

Active (4)

Discontinued (1)

Company Info